PAPER Su Y, Zeng X, Zhang L, Bian Y, Wang Y, Ma B
SEARCH RESULTS
340304 RESULTS
PAPER Behar AE, Maayan G
A cocktail of Cu2+- and Zn2+-peptoid-based chelators can stop ROS formation for Alzheimer's disease therapy.
Chem Sci. 2024 Oct 24; PubMed.PAPER Asadi Rizi A, Amjad L, Shahrani M, Amini Khoei H
A Systematic Review of the Role of Gummosin in Improving Memory in the Scopolamine Impaired Memory Model.
Arch Razi Inst. 2024 Apr;79(2):248-263. Epub 2024 Apr 30 PubMed.PAPER Tay SY, Koay WI, Ting SK, Liew TM
Examining the Measurement Equivalence of Alzheimer Disease Research Centers' Neuropsychological Test Battery (Version 3) Between Singapore and US Samples.
Alzheimer Dis Assoc Disord. 2024 Oct 28; PubMed.PAPER Ni Z, Tan J, Luo Y, Ye S
Dynamic protein hydration water mediates the aggregation kinetics of amyloid β peptides at interfaces.
J Colloid Interface Sci. 2024 Oct 21;679(Pt B):539-546. PubMed.PAPER Matveyenka M, Ali A, Mitchell CL, Brown HC, Kurouski D
Cholesterol Accelerates Aggregation of α-Synuclein Simultaneously Increasing the Toxicity of Amyloid Fibrils.
ACS Chem Neurosci. 2024 Oct 29; PubMed.PAPER Yang Y, Chen S, Gao Y, Huang L, Liu Z, Liu C, Fang X, Zhang Z
Complement Receptor 1 Is a Potential Extracerebral Factor Promoting α-Synuclein Pathology.
Mol Neurobiol. 2024 Oct 29; PubMed.PAPER Kawarabayashi T, Nakamura T, Takatama S, Miyamoto N, Iwai T, Naito I, Sugawara T, Ishizawa K, Hashimoto K, Amari M, Ikeuchi T, Kasahara H, Ikeda Y, Takatama M, Shoji M
A case of the iatrogenic transmission of vascular Aß40 amyloid.
Amyloid. 2024 Oct 29;:1-3. PubMed.PAPER Zhang J, Price CJ, Zhao K, Tang Y, Zhong S, Lou J, Ye X, Liang F
Associations between amyloid-β load and cognition in cerebrovascular disease beyond cerebral amyloid angiopathy: a systematic review and meta-analysis of positron emission tomography studies.
Age Ageing. 2024 Oct 1;53(10) PubMed.PAPER Fiorenzato E, Cauzzo S, Weis L, Garon M, Pistonesi F, Cianci V, Nasi ML, Vianello F, Zecchinelli AL, Pezzoli G, Reali E, Pozzi B, Isaias IU, Siri C, Santangelo G, Cuoco S, Barone P, Antonini A, Biundo R
Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson's disease: A data-driven decision tree model.
J Neurol Sci. 2024 Oct 22;466:123283. Epub 2024 Oct 22 PubMed.PAPER Jellinger KA
Mild cognitive impairment in amyotrophic lateral sclerosis: current view.
J Neural Transm (Vienna). 2024 Oct 29; PubMed.PAPER Manjavong M, Diaz A, Ashford MT, Aaronson A, Miller MJ, Kang JM, Mackin S, Tank R, Weiner M, Nosheny R, Alzheimer's Disease Neuroimaging Initiative
A short version of the Everyday Cognition scale can predict clinical progression and cognitive decline.
Alzheimers Dement. 2024 Oct 29; PubMed.PAPER Terstege DJ, Galea LA, Epp JR, Alzheimer's Disease Neuroimaging Initiative
Retrosplenial hypometabolism precedes the conversion from mild cognitive impairment to Alzheimer's disease.
Alzheimers Dement. 2024 Oct 29; PubMed.PAPER Wan Y, Zhao Y, Pan M, Gan J, Wu N, Zhang Y, Liu Z, Song L
Peripheral biomarkers of Parkinson's disease and its correlation with clinical symptoms: a case-control study.
BMC Neurol. 2024 Oct 28;24(1):417. PubMed.PAPER Sanaat A, Hu Y, Boccalini C, Salimi Y, Mansouri Z, Teixeira EP, Mathoux G, Garibotto V, Zaidi H
Tracer-Separator: A Deep Learning Model for Brain PET Dual-Tracer (18F-FDG and Amyloid) Separation.
Clin Nucl Med. 2024 Oct 29; PubMed.Current Filters
No filters selected